Diagnosis of toxic shock syndrome by two different systems; clinical criteria and monitoring of TSST‐1‐reactive T cells
Yoshio Matsuda(Tokyo Women's Medical University), Takehiko Uchiyama, Toshifumi Hibi∥(Kitasato Institute Hospital), Tetsuya Ogawa(Nihon University), T. Itoh(University of California, Los Angeles), Sayaka Inokuchi(Keio University), Erina Ono, Shun'ichi Itoh, Ken Kikuchi, Hiroaki Ohta(Sanno Medical Center), Koichiro Takagi(Tokyo Women's Medical University Adachi Medical Center), Ken’ichi Imanishi, Mitsue Muraoka(University of Tsukuba), Hidehito Kato, Kosaku Nitta(Tokyo Women's Medical University)
Cited by 7
Related Papers
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
|Gastroenterology|2013|938
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary
|Archives of Osteoporosis|2012|360
Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial
|Journal of Gastroenterology|2002|194